11,700 Shares in The Cooper Companies, Inc. $COO Purchased by Employees Retirement System of Texas

Employees Retirement System of Texas acquired a new stake in shares of The Cooper Companies, Inc. (NASDAQ:COO) in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 11,700 shares of the medical device company’s stock, valued at approximately $959,000.

Several other hedge funds and other institutional investors also recently bought and sold shares of COO. Bell Investment Advisors Inc increased its stake in shares of Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock worth $29,000 after buying an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in Cooper Companies during the 2nd quarter worth $36,000. True Wealth Design LLC increased its position in shares of Cooper Companies by 484.8% in the 4th quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock worth $38,000 after purchasing an additional 383 shares during the last quarter. Cromwell Holdings LLC increased its position in shares of Cooper Companies by 128.8% in the 4th quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock worth $40,000 after purchasing an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund bought a new position in shares of Cooper Companies during the fourth quarter worth about $41,000. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Cooper Companies Stock Down 2.0%

Shares of Cooper Companies stock opened at $60.80 on Thursday. The stock has a market capitalization of $11.86 billion, a price-to-earnings ratio of 30.10, a PEG ratio of 1.60 and a beta of 0.89. The Cooper Companies, Inc. has a twelve month low of $58.89 and a twelve month high of $89.83. The company has a current ratio of 1.34, a quick ratio of 0.79 and a debt-to-equity ratio of 0.22. The business’s 50 day simple moving average is $66.38 and its 200-day simple moving average is $75.02.

Cooper Companies (NASDAQ:COO) last released its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The business had revenue of $1.02 billion during the quarter, compared to analyst estimates of $1.02 billion. Cooper Companies had a return on equity of 10.34% and a net margin of 9.67%.The business’s revenue for the quarter was up 6.2% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.62 earnings per share for the current year.

Wall Street Analyst Weigh In

COO has been the subject of a number of research reports. William Blair upgraded Cooper Companies to a “strong-buy” rating in a research note on Friday, January 30th. Citigroup reduced their target price on Cooper Companies from $88.00 to $87.00 and set a “neutral” rating on the stock in a report on Friday, March 6th. Barclays upped their price target on Cooper Companies from $98.00 to $103.00 and gave the company an “overweight” rating in a research report on Friday, March 6th. Rothschild & Co Redburn cut Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price objective on the stock. in a research note on Wednesday, March 4th. Finally, The Goldman Sachs Group set a $61.00 price objective on shares of Cooper Companies in a report on Wednesday. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Cooper Companies currently has an average rating of “Moderate Buy” and a consensus price target of $89.93.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.